VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AORT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AORTArtivion, Inc.
$18.27$887M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAORTCash Flow

Artivion, Inc. (AORT) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow turned to -$17.6M in 2026Q3 (a -14.2% margin) as working capital drained $18.1M and CapEx rose to 10.5% of revenue, leaving operating cash conversion weak relative to reported earnings.

Income StatementBalance SheetCash FlowRatios

AORT Cash Flow Statement

Annual statement

AORT Cash Flow Statement

Artivion, Inc. (AORT) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations14.89M38.13M22.24M18.82M-5.15M-2.58M12.37M15.83M9.88M10.8M19.72M11.44M8.12M16.77M18.99M16.75M20.84M16.57M9.54M9.29M-1.07M-18.52M-16.23M-5.93M-2.11M6.48M10.28M987K1.2M-2.2M4M
Operating CF Margin %-8.64%5.72%5.32%-1.64%-0.86%4.88%5.73%3.76%5.69%10.93%7.84%5.61%11.92%14.42%14%17.86%14.84%9.08%9.81%-1.32%-26.73%-26.01%-9.96%-2.71%7.39%13.33%1.48%1.98%-4.32%10.81%
Operating CF Growth %-30.92%71.48%18.12%465.32%-99.34%-120.9%-21.85%60.18%-8.53%-45.22%72.34%40.95%-51.6%-11.68%13.37%-19.61%25.74%73.77%2.64%967.6%94.22%-14.12%-173.53%-181%-132.58%-36.97%941.44%-17.75%154.55%-155%263.64%
Net Income-17.59M9.77M-13.36M-30.69M-19.19M-14.83M-3.46M1.72M-2.84M3.7M10.78M4M7.32M16.17M7.95M7.37M3.94M8.68M32.91M7.2M365K-19.54M-18.75M-32.29M-27.76M9.17M7.82M4.45M6.5M4.7M3.9M
Depreciation & Amortization26.19M22.46M24.2M23.08M22.44M23.98M27.86M18.32M18.09M9.74M8.38M5.86M6.03M5.84M5.63M4.96M3.94M4.26M4.35M4.46M4.84M5.04M5.48M5.51M5.42M4.61M3.22M3.15M3.5M2.7M1.4M
Stock-Based Compensation22.8M24.39M14.24M14.42M12.34M10.71M6.91M8.8M6.33M6.92M6.33M5.09M3.44M3.24M3.16M2.79M2.62M2.43M2.1M2.13M1.62M358K358K00000000
Deferred Taxes686K37K-1.51M-1.39M-1.72M-4.47M4.28M-2.31M-4.49M-1.48M595K3.68M178K617K1.23M1.77M-1.51M5.25M-7K-961K226K3.55M7.19M5.73M-5.57M624K1.66M-970K-1.9M400K0
Other Non-Cash Items27.02M3.64M15.9M29.59M6.91M15.26M3.47M8.68M2.8M2.79M-6.28M718K-324K-7.52M1.31M1.04M7.73M652K-18.29M1.72M2.16M-2.48M10K347K38.01M348K616K1.19M-100K100K200K
Working Capital Changes-44.21M-22.16M-17.24M-16.19M-25.94M-33.23M-26.7M-19.38M-10.01M-10.87M-83K-7.91M-8.52M-1.58M-289K-1.17M4.11M-4.71M-11.52M-5.25M-10.28M-5.45M-10.52M7.9M-12.21M-8.98M-3.03M-6.84M-6.6M-10.1M-1.5M
Change in Receivables-10.38M-7.27M-15.39M-4.05M-13.34M-11.56M9.94M-3.38M-5.91M-7.26M4.14M-3.81M-4.56M-1.64M1.36M-2.23M179K-80.36M-68.24M2.78M-36.31M-29.87M-30.03M00000000
Change in Inventory-20.12M-15.28M-6.14M-14.36M-8.4M-18.38M-24.76M-8.13M2.38M-9.37M-9.46M-2.26M-1.13M193K-1.6M2.44M-1.8M-1.14M-2.92M-454K-600K158K-517K135K-1.43M-2.27M-1.43M-2.88M-3M-900K200K
Change in Payables-12.1M2.18M9.5M1.68M-1.96M-1.89M-9.16M251K-8.87M8.73M4.72M-656K-64K572K529K-772K2.38M483K267K842K155K342K342K00000000
Cash from Investing-183.43M-42.04M-28.19M-502K-10.71M5.66M-73.13M-23.94M-6.71M-170.99M-73.85M-4.49M-5.35M10.88M-22.92M-27.72M-10.73M-4.38M-4.34M446K-557K-2.03M457K9.35M6.28M-18.1M-6.63M-3.28M-18.9M-9.6M-4.9M
Capital Expenditures-59.27M-39.04M-11.19M-7.43M-10.71M-13.09M-7.33M-8.07M-5.79M-7.04M-7.42M-4.1M-5.32M-4.34M-3.07M-2.54M-7.53M-1.69M-1.74M-1.21M-1.64M-989K-950K-955K-4.1M-14.33M-9.49M-3.85M-6.7M-5.1M-9.2M
CapEx % of Revenue12.3%8.85%2.88%2.1%3.41%4.38%2.89%2.92%2.2%3.71%4.12%2.81%3.68%3.08%2.33%2.12%6.46%1.51%1.65%1.27%2.02%1.43%1.52%1.6%5.27%16.34%12.31%5.77%11.04%10.02%24.86%
Acquisitions-116.66M00000-59.12M00-163.92M-71.36M-1.35M198K0-17.04M-21.06M048K019K13K12K26K0000015M00
Investments-------------------------------
Other Investing-7.5M-3M-17M6.93M0-249K-6.68M-15.87M-929K-86K4.87M3K-192K-206K-2.81M-547K-797K-831K-46K-190K-105K-208K-56K1.25M-1.43M1.33M43K-452K-700K-4.5M-1.6M
Cash from Financing144M13.03M2.2M865K-1.64M-12.22M93.61M-1.49M-2.56M143.25M73.43M-2.81M-6.95M-3.05M-4.71M-2.85M-4.72M707K-2.43M743K-968K22.73M15.55M-8.03M-1.4M1.33M7.78M-4.46M30.5M10.6M1.8M
Debt Issued (Net)145.71M-2.46M-358K-2.77M-2.75M-3.08M94.65M-2.78M-2.79M152.79M73.59M0000-31K-1.54M-1.33M-4.2M-41K-2.76M3.79M-717K-6.25M-2.21M-176K6.37M-738K-12.5M10M1.2M
Equity Issued (Net)7.58M13.07M5.73M-559K-1.79M-1.91M-2M-2.74M-2.1M-1.61M-697K-1.39M-7.07M-2.2M-3.53M-3.06M-5.88M-330K1.77M1.27M418K19.47M19.65M660K809K1.5M1.05M-3.73M42.9M600K600K
Dividends Paid00000000000-3.41M-3.29M-2.97M-1.37M0000-486K-973K-533K000000000
Share Repurchases000-559K-1.79M-1.91M-2M-2.74M-2.1M-1.61M-697K-1.39M-7.07M-1.52M-3.53M-3.06M-5.88M-330K-611K-478K-50K0-54K0-663K0-612K-4.3M-3.4M00
Other Financing-9.29M2.42M-3.17M4.2M2.91M-7.22M949K4.03M2.33M-7.93M531K1.98M3.41M2.12M187K249K2.69M2.37M002.35M0-3.38M-2.44M00360K0100K00
Net Change in Cash-25.03M11.45M-5.48M19.59M-15.66M-6.95M27.66M-7.94M1.48M-16.66M19.05M4.21M-4.27M24.63M-8.7M-13.79M5.38M12.92M2.74M10.33M-2.5M1.92M-184K-4.61M3.07M-10.28M11.35M-6.76M30.5M10.6M1.8M
Free Cash Flow-44.38M-911K11.05M11.39M-15.87M-15.68M5.04M7.75M4.09M3.76M12.29M7.34M2.8M12.43M15.92M14.21M13.3M14.88M7.8M8.09M-2.71M-19.51M-17.18M-6.89M-6.21M-7.85M788K-2.87M-5.5M-7.3M-5.2M
FCF Margin %-9.21%-0.21%2.84%3.22%-5.06%-5.25%1.99%2.81%1.56%1.98%6.82%5.03%1.93%8.83%12.09%11.88%11.41%13.33%7.42%8.53%-3.34%-28.15%-27.53%-11.57%-7.98%-8.95%1.02%-4.3%-9.06%-14.34%-14.05%
FCF Growth %-381.77%-108.25%-3.05%171.81%-1.22%-410.97%-35%89.38%8.85%-69.4%67.53%162.29%-77.5%-21.9%12.01%6.82%-10.6%90.82%-3.54%398.01%86.09%-13.57%-149.4%-10.88%20.88%-1096.19%127.49%47.89%24.66%-40.38%-940%
FCF per Share-0.91-0.020.270.28-0.40-0.400.130.200.110.110.370.260.100.450.580.510.470.530.280.30-0.11-0.81-0.75-0.35-0.32-0.400.04-0.15-0.30-0.49-0.35
FCF Conversion (FCF/Net Income)2.52x3.90x-1.66x-0.61x0.27x0.17x-0.74x9.20x-2.60x2.92x1.83x2.86x1.11x1.04x2.39x2.27x5.28x1.91x0.29x1.29x-2.93x0.95x0.87x0.18x0.08x0.71x1.31x0.22x0.18x-0.47x1.03x
Interest Paid0000000000000000000000000000000
Taxes Paid0000000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Negative operating cash conversion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Fails to Track Earnings

Based on reported quarterly figures, Artivion's operating cash flow to net income ratio swung from -5.01 to 33.57 over the ten quarters, with 2026Q3 showing a net loss of -$7.9M alongside negative operating cash flow of -$4.6M, indicating reported earnings are a poor guide to cash generation.

The extreme ratio volatility is driven by small denominators when net income approaches zero, which makes the ratio itself unreliable as a quality signal; the absolute cash figures are more informative. Operating cash flow was positive in only six of ten quarters and turned negative in both 2025Q1 and 2026Q3, suggesting working capital swings rather than steady earnings conversion are driving results. Investors should monitor whether operating cash flow stabilizes once working capital normalizes, as the current pattern warrants further investigation.

Free Cash Flow Turns Persistently Negative

According to the reported cash flow statements, Artivion's free cash flow margin deteriorated to -14.2% in 2026Q3 and has been negative in four of the last five quarters, with FCF of -$17.6M in the latest period compared with +$15.9M a year earlier.

The shift from positive FCF in 2025Q2 and 2025Q3 to consecutive losses in 2026 appears to reflect both weaker operating cash and elevated capital expenditure in 2025Q4 and 2026Q3. Cumulative negative free cash flow across the most recent five quarters suggests the business is not currently self-funding its investment needs on reported figures. This may indicate tighter cash headroom, which warrants monitoring alongside the disclosed balance sheet.

Capital Spending Spikes Without Clear Payoff

Based on reported capital expenditure, Artivion's CapEx-to-revenue ratio rose to 23.7% in 2025Q4 and 10.5% in 2026Q3, sharply above the 1.5% to 4.1% range seen across most of 2024 and 2025, with combined quarterly outlays of $27.5M and $13.0M in those two periods.

Spending at these levels is well above the D&A run-rate of roughly $5.5M to $7.3M per quarter, implying a meaningful growth or facility-expansion component rather than pure maintenance. Because the reported data does not break out maintenance versus growth capex, the split cannot be verified, and the return on this investment is not yet visible in operating cash flow. Analysts should track whether these outlays translate into revenue or margin gains in subsequent periods.

Working Capital Drains Drive Cash Volatility

As reported in the quarterly statements, working capital changes consumed $18.1M in 2026Q3, $19.1M in 2026Q1, and $26.8M in 2025Q1, representing the largest negative swings in the ten-quarter series and accounting for much of the operating cash volatility.

Repeated large working capital outflows, following a period of inflows in 2024 and 2025Q3 to 2025Q4, suggest receivables, inventory build, or payables timing may be absorbing cash. The reported data does not isolate these components, so the specific driver cannot be determined from the supplied figures. Investors should monitor inventory levels and collection periods to assess whether the pattern is timing-related or structural.

Cumulative Earnings Versus Cash Gap

Based on reported quarterly figures, cumulative net income over the ten quarters is approximately -$31.1M while cumulative operating cash flow is roughly +$58.2M, suggesting that non-cash charges and timing effects have pushed cash generation above reported earnings over this window.

The positive divergence is partly explained by D&A of roughly $60M and stock-based compensation of about $29M across the period, both non-cash add-backs that inflate operating cash relative to net income. However, the net positive gap reverses sign in the most recent quarters, indicating the add-backs are not fully offsetting working capital and earnings pressure. Investors should weigh whether the cumulative cash strength is sustainable or reflects one-time timing benefits that may unwind.

Cash Strength May Mask Underlying Strain

Based on reported figures, the cumulative operating cash flow surplus over the ten quarters may overstate underlying cash health, since add-backs for stock-based compensation and D&A and favorable working capital periods in 2024 and 2025 could be masking recent deterioration.

Stock-based compensation is a real economic cost that is added back in operating cash flow, so the reported cash figures may flatter the company's true cash-generating capacity relative to a cash-settled cost base. The reported data does not disclose capitalized costs, off-balance-sheet obligations, or the composition of working capital movements, so these potential distortions cannot be verified. Investors should treat the cumulative cash surplus with caution and monitor whether recent negative free cash flow persists once working capital normalizes.

AORT — Frequently Asked Questions

Quick answers to the most common questions about buying AORT stock.

How much cash does Artivion, Inc. (AORT) generate from operations?

Artivion, Inc. (AORT) generated $38.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Artivion, Inc.'s free cash flow?

Artivion, Inc. (AORT) reported negative free cash flow of $0.9M in 2025, indicating capital requirements exceeded cash from operations.

What is Artivion, Inc.'s capital expenditure (CapEx)?

Artivion, Inc. (AORT) spent $39.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.